Clay Catherine R
Former Officer at CBOE
- Sold, on record
- $2.2M
- Dollars the filings state
- Form 4 sales
- 6
- Latest May 23, 2025
- Form 144 notices
- 6
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CBOECboe Global Markets, Inc.Former Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale CBOENo planMay 9, 2024 2024
Sold 1,100 shares at $185.06 ($204k)
Clay Catherine R, EVP, GLOBAL DERIVATIVES
No 10b5-1 planSold 19.1% of holdings ($1.1M position)4,656 shares leftFollows a Form 144Filing
- 2 Form 144 notice CBOENoticeAug 7, 2024 +90 days
Filed to sell 600 shares ($122k)
Clay Catherine R, Officer
No 10b5-1 plan0.5x usual sizeFiling
- 3 Form 4 sale CBOENo planAug 7, 2024 same day
Sold 600 shares at $203.23 ($122k)
Clay Catherine R, EVP, GLOBAL DERIVATIVES
No 10b5-1 planSold 12.2% of holdings ($1M position)4,328 shares left0.5x usual sizeFollows a Form 144Filing
- 4 Form 144 notice CBOENoticeFeb 10, 2025 +187 days
Filed to sell 3,000 shares ($636k)
Clay Catherine R, Officer
No 10b5-1 plan2.7x usual sizeFiling
- 5 Form 4 sale CBOEUnusualFeb 10, 2025 same day
Sold 3,000 shares at $211.85 ($636k)
Clay Catherine R, EVP, GLOBAL DERIVATIVES
No 10b5-1 planSold 69.3% of holdings ($917k position)1,328 shares left2.7x usual sizeFollows a Form 144Filing
- 6 Form 144 notice CBOENoticeMay 23, 2025 +102 days
Filed to sell 3,598 shares ($815k)
Clay Catherine R, Officer
10b5-1 plan3x usual sizeFiling
- 7 Form 4 sale CBOERoutineMay 23, 2025 same day
Sold 3,598 shares at $226.58 ($815k)
Clay Catherine R, EVP, GLOBAL DERIVATIVES
10b5-1 planSold 62.2% of holdings ($1.3M position)2,183 shares left3x usual sizeFollows a Form 144Filing
- 8 Form 144 notice CBOENoticeNov 7, 2025 +168 days
Filed to sell 2,183 shares ($557k)
Clay Catherine R, Former Officer
No 10b5-1 plan1.7x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (12)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 7, 2025 | Nov 7, 2025 | CBOE | Former Officer | Form 144 notice | 2,183 | $557k | Notice | SEC | |
| May 23, 2025 | May 28, 2025 | CBOE | EVP, GLOBAL DERIVATIVES | Form 4 sale | 3,598 | $815k | 62.2% | Routine | SEC |
| May 23, 2025 | May 23, 2025 | CBOE | Officer | Form 144 notice | 3,598 | $815k | Notice | SEC | |
| Feb 10, 2025 | Feb 12, 2025 | CBOE | EVP, GLOBAL DERIVATIVES | Form 4 sale | 3,000 | $636k | 69.3% | Unusual | SEC |
| Feb 10, 2025 | Feb 10, 2025 | CBOE | Officer | Form 144 notice | 3,000 | $636k | Notice | SEC | |
| Aug 7, 2024 | Aug 9, 2024 | CBOE | EVP, GLOBAL DERIVATIVES | Form 4 sale | 600 | $122k | 12.2% | No plan | SEC |
| Aug 7, 2024 | Aug 7, 2024 | CBOE | Officer | Form 144 notice | 600 | $122k | Notice | SEC | |
| May 9, 2024 | May 13, 2024 | CBOE | EVP, GLOBAL DERIVATIVES | Form 4 sale | 1,100 | $204k | 19.1% | No plan | SEC |
| May 9, 2024 | May 9, 2024 | CBOE | Officer | Form 144 notice | 1,100 | $204k | Notice | SEC | |
| Nov 24, 2023 | Nov 28, 2023 | CBOE | EVP, GLOBAL DERIVATIVES | Form 4 sale | 1,300 | $234k | 23.6% | No plan | SEC |
| Nov 24, 2023 | Nov 24, 2023 | CBOE | Officer | Form 144 notice | 1,300 | $234k | Notice | SEC | |
| Sep 7, 2022 | Sep 9, 2022 | CBOE | EVP, DATA AND ACCESS SOLUTIONS | Form 4 sale | 1,182 | $147k | 25.4% | Unusual | SEC |